
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.4 | -3.12151616499 | 44.85 | 44.94 | 42.22 | 299278 | 43.24066859 | CS |
4 | 3.74 | 9.41828254848 | 39.71 | 52.88 | 37.785 | 730541 | 46.76204779 | CS |
12 | 4.41 | 11.2961065574 | 39.04 | 52.88 | 31.4201 | 522255 | 42.02780597 | CS |
26 | -8.67 | -16.6346891788 | 52.12 | 56 | 31.4201 | 459267 | 42.78208756 | CS |
52 | 4.95 | 12.8571428571 | 38.5 | 58.26 | 31.4201 | 371326 | 44.81763262 | CS |
156 | 38.25 | 735.576923077 | 5.2 | 64.98 | 4.88 | 373142 | 43.97016052 | CS |
260 | 31.08 | 251.253031528 | 12.37 | 64.98 | 4.25 | 359403 | 42.84276329 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.